BiOasis Technologies Inc logo

BTI - BiOasis Technologies Inc Share Price

C$0.38 0.0  0.0%

Last Trade - 05/03/21

Micro Cap
Market Cap £15.5m
Enterprise Value £14.0m
Revenue £2.35m
Position in Universe 1414th / 2682
Unlock BTI Revenue
Relative Strength (%)
1m -21.2%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -45.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 29th Feb 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.37 0.51 0.59 1.42 0.61 6.39 2.66
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 30 November 2020, biOasisTechnologies Inc revenues increased from C$569K to C$4.1M.Net income totaled C$1.8M vs. loss of C$3M. Revenuesreflect an increase in demand for the Company's productsand services due to favorable market conditions. Net Incomereflects Salaries and consulting decrease of 38% to C$1.1M(expense), Labor & Related Expenses in R&D decrease of 61%to C$177K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


BTI Revenue Unlock BTI Revenue

Net Income

BTI Net Income Unlock BTI Revenue

Normalised EPS

BTI Normalised EPS Unlock BTI Revenue

PE Ratio Range

BTI PE Ratio Range Unlock BTI Revenue

Dividend Yield Range

BTI Dividend Yield Range Unlock BTI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BTI EPS Forecasts Unlock BTI Revenue
Profile Summary

biOasis Technologies Inc. is a development-stage biopharmaceutical company, which is focused on research, development and commercialization of technologies and products that are intended for the treatment of central nervous system (CNS) diseases and diseases of the brain. The Company researches and develops products for diagnosis and treatment of neurological diseases and disorders. It is engaged in the development of its vectors Transcend and Transcendpep for the transport of therapeutic agents across the blood brain barrier (BBB). The Transcend brain delivery platform exploits the BBB penetrating properties of a recombinant soluble human protein known as melanotransferrin (MTf or p97) and portions thereof. Transcend delivery molecules have the ability to transport a range of molecules across the BBB. The Company owns approximately 30 the United States and foreign patents/applications related to p97 as a BBB delivery vector and as a biomarker for Alzheimer's disease.

Last Annual February 29th, 2020
Last Interim November 30th, 2020
Incorporated November 3, 2006
Public Since October 27, 1993
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange TSX Venture Exchange
Shares in Issue 71,444,015
Free Float (0.0%)
Eligible for
BTI Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BTI
Upcoming Events for BTI
Frequently Asked Questions for biOasis Technologies Inc
What is the biOasis Technologies Inc share price?

As of 05/03/21, shares in biOasis Technologies Inc are trading at C$0.38, giving the company a market capitalisation of £15.5m. This share price information is delayed by 15 minutes.

How has the biOasis Technologies Inc share price performed this year?

Shares in biOasis Technologies Inc are currently trading at C$0.38 and the price has moved by 52% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the biOasis Technologies Inc price has moved by 35.64% over the past year.

What are the analyst and broker recommendations for biOasis Technologies Inc?

Of the analysts with advisory recommendations for biOasis Technologies Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for biOasis Technologies Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will biOasis Technologies Inc next release its financial results?

biOasis Technologies Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-11-30
What is the biOasis Technologies Inc dividend yield?

biOasis Technologies Inc does not currently pay a dividend.

Does biOasis Technologies Inc pay a dividend?

biOasis Technologies Inc does not currently pay a dividend.

When does biOasis Technologies Inc next pay dividends?

biOasis Technologies Inc does not currently pay a dividend.

How do I buy biOasis Technologies Inc shares?

To buy shares in biOasis Technologies Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of biOasis Technologies Inc?

Shares in biOasis Technologies Inc are currently trading at C$0.38, giving the company a market capitalisation of £15.5m.

Where are biOasis Technologies Inc shares listed? Where are biOasis Technologies Inc shares listed?

Here are the trading details for biOasis Technologies Inc:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: BTI
What kind of share is biOasis Technologies Inc?

Based on an overall assessment of its quality, value and momentum, biOasis Technologies Inc is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a biOasis Technologies Inc share price forecast 2021?

We were not able to load any forecast data for biOasis Technologies Inc.

How can I tell whether the biOasis Technologies Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like biOasis Technologies Inc. Over the past six months, the relative strength of its shares against the market has been -9.99%. At the current price of C$0.38, shares in biOasis Technologies Inc are trading at 10.53% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the biOasis Technologies Inc PE Ratio?

The biOasis Technologies Inc PE ratio based on its reported earnings over the past 12 months is 23.18. The shares are currently trading at C$0.38.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of biOasis Technologies Inc?

biOasis Technologies Inc's management team is headed by:

Doug Williams - EVP
Deborah Rathjen - CHM
John Curran - IND
David Wurzer - IND
Christine Antalik - CFO
Mario Saltarelli - NED
Caroline Dircks - COO
Who are the major shareholders of biOasis Technologies Inc?

Here are the top five shareholders of biOasis Technologies Inc based on the size of their shareholding:

Hemeon (John M) Individual Investor
Percentage owned: 1.88% (1.34m shares)
Rathjen (Deborah Ann) Individual Investor
Percentage owned: 0.25% (179k shares)
Curran (John E.) Individual Investor
Percentage owned: 0.07% (53.5k shares)
Wurzer (David M) Individual Investor
Percentage owned: 0.07% (53.6k shares)
Similar to BTI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.